索引超出了数组界限。
[1] Li J, Huang NF, Zou J, et al. Conversion of human fibroblasts to functional endothelial cells by defined factors[J]. Arterioscler Thromb Vasc Biol, 2013, 33(6):1366-1375.
[2] Caiazzo M, Giannelli S, Valente P, et al. Direct conversion of fibroblasts into functional astrocytes by defined transcription factors[J]. Stem Cell Reports, 2015, 4(1):25-36.
[3] Ubil E, Duan J, Pillai IC, et al. Mesenchymal-endothelial transition contributes to cardiac neovascularization[J]. Nature, 2014, 514(7524):585-590.
[4] Qian L, Huang Y, Spencer CI, et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes[J]. Nature, 2012, 485(7400):593-598.
[5] Song K, Nam YJ, Luo X, et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors[J]. Nature, 2012, 485(7400):599-604.
[6] Zhou Q, Brown J, Kanarek A, et al. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells[J]. Nature, 2008, 455(7213):627-632.
[7] Motoyama H, Ogawa S, Kubo A, et al. In vitro reprogramming of adult hepatocytes into insulin-producing cells without viral vectors[J]. Biochem Biophys Res Commun, 2009, 385(1):123-128.
[8] Brumm AJ, Nunez S, Doroudchi MM, et al. Astrocytes canadopt endothelial cell fates in a p53-dependent manner[J]. Mol Neurobiol, 2016, Jul 8. [Epub ahead of print].
[9] Li W, Li K, Wei W, et al. Chemical approaches to stem cell biology and therapeutics[J]. Cell Stem Cell, 2013, 13(3):270-283.
[10] Liu K, Yu C, Xie M, et al. Chemical modulation of cell fate in stem cell therapeutics and regenerative medicine[J]. Cell Chem Biol, 2016, 23(8):893-916.
[11] Sayed N, Wong WT, Ospino F, et al. Transdifferentiation of human fibroblasts to endothelial cells: role of innate immunity[J]. Circulation, 2015, 131(3):300-309.
[12] Brevini TA, Pennarossa G, Rahman MM, et al. Morphological and molecular changes of human granulosa cells exposed to 5-azacytidine and addressed toward muscular differentiation[J]. Stem Cell Rev, 2014, 10(5):633-642.